Curing or even finding treatments for rare diseases is hard. Not necessarily because these diseases are any more complex than more common ones. It...

Scientist’s CEO, Kevin Lustig, spoke in a recent episode of the Burrill Report about the Open Science movement and how the democratization of drug...

Scientist is pleased to announce the Rare Disease Science Challenge: Be HEARD (Helping Empower and Accelerate Research Discoveries). We are working...

In James Surowiecki’s book “The Wisdom of Crowds”, he lays out the criteria for successful decision making by large groups1: Diversity of opinion...

The Make Your Mark competition, part of Scientist’s Open Science Challenge series, is now officially live in San Diego, New York, and Boston...

For decades the model for how a clinical diagnostic assay (otherwise known as a clinical diagnostic, or a diagnostic test) was developed remained...

“Open source”, a term synonymous to computer programming, is a pragmatic methodology that promotes redistribution and access to an end product. In...

Yesterday we published in Scientific American’s blog a call to action about the Scientist-sponsored Rare Disease Science Challenge. If you or a...

A Scientist user reminded me last week of Atul Butte’s TEDMED 2012 talk, which showcases Scientist’s outsourcing marketplace. While speaking about...

There is an argument that says we should not be making simple compounds in academic research labs, but rather using specialist services to make...